Standard
Cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder : a neuropharm study. / Dam, V. H.; Stenbaek, D. S.; Kohler-Forsberg, K.; Ip, C.; Ozenne, B.; Sahakian, B. J.; Knudsen, G. M.; Jorgensen, M. B.; Frøkjær, V. G.
I:
European Neuropsychopharmacology, Bind 53, 2021, s. S276-S277.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Harvard
Dam, VH
, Stenbaek, DS, Kohler-Forsberg, K, Ip, C
, Ozenne, B, Sahakian, BJ
, Knudsen, GM, Jorgensen, MB & Frøkjær, VG 2021, '
Cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: a neuropharm study',
European Neuropsychopharmacology, bind 53, s. S276-S277.
https://doi.org/10.1016/j.euroneuro.2021.10.358APA
Dam, V. H.
, Stenbaek, D. S., Kohler-Forsberg, K., Ip, C.
, Ozenne, B., Sahakian, B. J.
, Knudsen, G. M., Jorgensen, M. B., & Frøkjær, V. G. (2021).
Cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: a neuropharm study.
European Neuropsychopharmacology,
53, S276-S277.
https://doi.org/10.1016/j.euroneuro.2021.10.358Vancouver
Dam VH
, Stenbaek DS, Kohler-Forsberg K, Ip C
, Ozenne B, Sahakian BJ o.a.
Cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: a neuropharm study.
European Neuropsychopharmacology. 2021;53:S276-S277.
https://doi.org/10.1016/j.euroneuro.2021.10.358Author
Dam, V. H. ; Stenbaek, D. S. ; Kohler-Forsberg, K. ; Ip, C. ; Ozenne, B. ; Sahakian, B. J. ; Knudsen, G. M. ; Jorgensen, M. B. ; Frøkjær, V. G. / Cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder : a neuropharm study. I: European Neuropsychopharmacology. 2021 ; Bind 53. s. S276-S277.
Bibtex
@article{5d1dd9ea40be4e4faf22f7bb1da0f774,
title = "Cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: a neuropharm study",
author = "Dam, {V. H.} and Stenbaek, {D. S.} and K. Kohler-Forsberg and C. Ip and B. Ozenne and Sahakian, {B. J.} and Knudsen, {G. M.} and Jorgensen, {M. B.} and Fr{\o}kj{\ae}r, {V. G.}",
year = "2021",
doi = "10.1016/j.euroneuro.2021.10.358",
language = "English",
volume = "53",
pages = "S276--S277",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
}
RIS
TY - ABST
T1 - Cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder
T2 - a neuropharm study
AU - Dam, V. H.
AU - Stenbaek, D. S.
AU - Kohler-Forsberg, K.
AU - Ip, C.
AU - Ozenne, B.
AU - Sahakian, B. J.
AU - Knudsen, G. M.
AU - Jorgensen, M. B.
AU - Frøkjær, V. G.
PY - 2021
Y1 - 2021
U2 - 10.1016/j.euroneuro.2021.10.358
DO - 10.1016/j.euroneuro.2021.10.358
M3 - Conference abstract in journal
VL - 53
SP - S276-S277
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
SN - 0924-977X
ER -
